Nutrient-Stimulated Hormone (NuSH) analogs have the potential to improve physical, mental, and social well-being on a population level. But NuSH analog availability, access, and persistence are limiting factors. Moving from current utilization rates of ~6% to 60% will require systematic scaling. But how? This symposium will examine solutions – new approaches to peptide engineering, scaled manufacturing, reduced disutility, and non-traditional care delivery models.
*Corporate Symposia events are open to a limited number of attendees, and registration is on a first-come, first-served basis. If you pre-registered for an event(s), you received a ticket(s) with your badge. Log in to your registration online or visit Assisted Registration to check event availability or to register for additional symposia. Seats are limited; plan to arrive 15 minutes prior to the event. Symposia planners reserve the right to allow walk-ins to fill vacant seats.*
